The cell line RN33B has been reported to differentiate into neurons in a site-specific manner when grafted to the cortex and hippocampus of adult rats. To investigate the fate of RN33B cells in a subcortical structure, we grafted RN33B cells into the intact or excitoxically lesioned striatum of adult or neonatal rats. The total number and phenotypic characteristics of the [ 3 H]thymidine-labeled grafted cells were analyzed at different time points after transplantation. Transplanted RN33B cells were found to survive, integrate, and differentiate into both neurons and astrocytes, and a significant proportion of the cells (approx. 10%) were found to differentiate into cells with morphological and phenotypic characteristics of medium-sized striatal projection neurons. Retrograde tracing showed that at least some of the graft-derived neurons were capable of establishing connections with one of the primary striatal targets, the globus pallidus. These findings demonstrate a remarkable capacity of the RN33B cells for site-specific neuronal differentiation in both the adult and the developing striatum and suggest that the same differentiating factors that are operating during normal neurogenesis in brain development are retained, at least to some extent, also in the adult CNS. r
INTRODUCTION
Immature neurons and neuroblasts, taken from the developing central nervous system, possess a remarkable capacity to integrate structurally and functionally after implantation into the brain of immature or adult recipients. Experiments performed in animal models of neurodegenerative diseases have shown that fetal cell transplants, at least to some degree, can restore lost neuronal connections and substitute functionally for lost neurons in the damaged brain (see Bjö rklund, 1991; Dunnett & Bjö rklund, 1994 , for recent reviews). Neuronal replacement by intracerebral cell transplantation is currently being explored in clinical trials as a new therapeutic strategy to promote functional recovery and/or to block the disease process in neurodegenerative disorders, such as Parkinson's and Huntington's disease (see Lindvall, 1994; Peschanski et al., 1995) .
For the further development of the cell transplantation approach, however, it is essential to find alternative sources of cells for grafting. The use of tissue from aborted human fetuses is not only ethically controversial, but it is problematic also because tissue obtained in routine abortions is difficult to standardize, may be contaminated, and is potentially in very limited supply. Neural stem or progenitor cells offer a particularly attractive alternative since they may be expanded and standardized in vitro and thus provide a virtually uniform source of well-characterized cell preparations for transplantation purposes (Gage et al., 1995; Whittemore & Snyder, 1996) . The most promising results so far have been obtained with immortalized CNSderived neural stem/progenitor cell lines, using either the temperature-sensitive (ts) mutant of SV40 Large T-antigen or v-myc for immortalization. These cells can be propagated extensively in vitro, but after transplan-
